Celebrex has been shown to increase the risk of heart attack and stroke

[Guest guest]

Defective Drug Newsletter - March 2007- Providing Unbiased Information on Controversial DrugsFeatured Stories http://www.adrugrecall.com/news/celebrex-last-resort.htmlCelebrex Should Be Last Resort, Heart Experts Say - March 5, 2007The American Heart Association issued strict guidelines last week for use of the controversial cox-2 painkiller Celebrex, which has been shown to increase the risk of heart attack and stroke. In a statement published in the journal Circulation , the association said that doctors should use Celebrex and other cox-2 painkillers only as a last resort in patients with or at risk for heart disease. read full article Regulators Reviewing Children's Cough Drugs For Safety - February 28, 2007The U.S. Food and Drug Administration announced they've started a wide safety review of all popular childrens' cough and cold drugs after recent studies found a higher incident of injury and death linked to the use of such remedies. Many of these drugs have not received thorough safety evaluations so the agency will revisit “the risks and benefits of the use of these drugs in children” and are particularly concerned about the safety of use in those under 2 years of age. read full article Some Vitamins May Raise Mortality Risk, Researcher Say - February 27, 2007The results of a new study suggests that some vitamin supplements taken every day by millions of people to boost their health could actually be increasing their risk of death. The Danish-led study, published in the Journal of the American Medical Association, analyzed previous data on vitamin A, vitamin C, vitamin E, beta carotene, and selenium to determine the safety and efficacy of these supplements. read full article Tamoxifen Linked to Eye Problems - February 26, 2007The popular drug tamoxifen—prescribed to prevent the recurrence of breast cancer—may be increasing the risk of optical problems such as swelling in the eyes, according to a new study. Tamoxifen helps prevent cancer recurrence by blocking estrogen receptors in the breast, while new types of drugs—aromatase inhibitors—hinder estrogen production. read full article FDA Pushes for Heightened Warning on Xolair - February 25, 2007The Food and Drug Administration has asked that the warning label on the asthma drug Xolair be strengthened to underscore the risk of anaphylaxis—a potentially fatal allergic reaction. Xolair, a Genentech, Inc. drug, is approved to treat allergy-related asthma in patients 12 and older. Early clinical trials showed that anaphylaxis occurred in approximately one in 1,000 patients, which was reflected on the drug's initial labeling read full article If you have any questions, concerns or comments regarding this newsletter please contact us. View our newsletter archiveConsumer Drug Safety New Anti-Inflammatory Drug GuidelinesAccording to new guidelines by the American Heart Association, patients being treated for chronic pain are advised to avoid taking all nonsteroidal anti-inflammatory drugs (NSAIDs) drugs—at least at first—because of the increased risk of heart attacks and strokes posed by these medications. Strong evidence has linked the use of NSAIDs (other than aspirin) with severe cardiovascular complications that could lead to lifelong injury or death. Researchers say that if 100 patients who have suffered a previous heart attack or are at risk for heart disease use NSAIDs for 12 months, six of them will die. Read More... Research a DrugAsk A Legal QuestionAre you concerned about a drug you are currently taking? Would you like expert advice on your legal rights regarding a particular drug? Free Legal Consultation.Breaking News Zyprexa Update March 2007In the past year, Eli Lilly has settled more than 25,000 Zyprexa lawsuits. Many of the complaints accused the company of concealing the risks—including the development of diabetes—associated with its popular antipsychotic, which is still on the market. Despite the recent settlements, the company is still plagued by hundreds of additional lawsuits. Distinguished attorney Pete Miller is dedicated to helping victims of dangerous drugs get the compensation they deserve and is currently accepting Zyprexa cases. However, time is limited. If you have suffered an adverse Zyprexa side effect, you may be eligible to recover your losses by filing a legal claim. Please contact us today for a FREE consultation with a skilled and respected attorney who will work tirelessly to maximize your legal rights and interests. -------------- Powered by CMTM Inc. | 527 Encinitas Blvd. | Encinitas | CA | 92024